A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD
Retina Synthesis - A podcast by Retina Synthesis
Categories:
In our latest update, We discuss the results of a one year Phase I trial exploring the use of a tyrosinase inhibitor in an hydrogel implant for the treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology, USC Roski Eye Institute.
